William Blair & Company’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-5,800
| Closed | -$407K | – | 1810 |
|
|
2018
Q3 | $407K | Buy |
5,800
+1,600
| +38% | +$112K | ﹤0.01% | 1031 |
|
|
2018
Q2 | $212K | Buy |
+4,200
| New | +$212K | ﹤0.01% | 1248 |
|
|
2015
Q1 | – | Sell |
-27,260
| Closed | -$871K | – | 2209 |
|
|
2014
Q4 | $871K | Sell |
27,260
-650
| -2% | -$20.8K | ﹤0.01% | 1535 |
|
|
2014
Q3 | $790K | Sell |
27,910
-700
| -2% | -$19.8K | ﹤0.01% | 1550 |
|
|
2014
Q2 | $783K | Sell |
28,610
-350
| -1% | -$9.58K | ﹤0.01% | 1530 |
|
|
2014
Q1 | $762K | Buy |
28,960
+7,260
| +33% | +$191K | ﹤0.01% | 1492 |
|
|
2013
Q4 | $635K | Buy |
21,700
+1,200
| +6% | +$35.1K | ﹤0.01% | 1517 |
|
|
2013
Q3 | $626K | Sell |
20,500
-550
| -3% | -$16.8K | ﹤0.01% | 1486 |
|
|
2013
Q2 | $667K | Buy |
+21,050
| New | +$667K | ﹤0.01% | 1409 |
|